The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 57,618,742 | 2,405,793 | SH | SOLE | 2,405,793 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,349,112 | 160,800 | SH | SOLE | 160,800 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 26,383,312 | 74,605 | SH | SOLE | 74,605 | 0 | 0 | ||
ALKERMES PLC | COM | G01767105 | 18,886,420 | 603,400 | SH | SOLE | 603,400 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 132,181,716 | 10,524,022 | SH | SOLE | 10,524,022 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 8,771,096 | 431,224 | SH | SOLE | 431,224 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 108,608,178 | 381,282 | SH | SOLE | 381,282 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 158,714,114 | 1,831,035 | SH | SOLE | 1,831,035 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 3,644,209 | 111,717 | SH | SOLE | 111,717 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 22,024,607 | 2,739,379 | SH | SOLE | 2,739,379 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 4,158,182 | 3,465,152 | SH | SOLE | 3,465,152 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 1,298,948 | 666,127 | SH | SOLE | 666,127 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 124,268,260 | 5,889,491 | SH | SOLE | 5,889,491 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 10,159,818 | 5,675,876 | SH | SOLE | 5,675,876 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 1,607,690 | 656,200 | SH | SOLE | 656,200 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,673,789 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 4,734,704 | 186,259 | SH | SOLE | 186,259 | 0 | 0 | ||
NOVOCURE LTD | COM | G6674U108 | 23,991,897 | 578,118 | SH | SOLE | 578,118 | 0 | 0 | ||
PROTHENA CORP PLC | COM | G72800108 | 113,171,232 | 1,657,458 | SH | SOLE | 1,657,458 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 1,801,704 | 732,400 | SH | SOLE | 732,400 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 132,336,094 | 5,228,609 | SH | SOLE | 5,228,609 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 40,414,489 | 859,517 | SH | SOLE | 859,517 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 10,768,316 | 94,030 | SH | SOLE | 94,030 | 0 | 0 | ||
STAAR SURGICAL CO | COM | 852312305 | 72,274,393 | 1,374,822 | SH | SOLE | 1,374,822 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 12,821,718 | 612,600 | SH | SOLE | 612,600 | 0 | 0 | ||
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 675,603 | 27,100 | SH | SOLE | 27,100 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 2,550,820 | 166,069 | SH | SOLE | 166,069 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 138,523,716 | 627,514 | SH | SOLE | 627,514 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 253,575 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 2,135,641 | 324,073 | SH | SOLE | 324,073 | 0 | 0 |